ULTRALIFE CORP
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $191.2M | $164.5M | $158.6M | $131.8M | $98.3M |
| Cost of revenue | $145.1M | $122.1M | $119.4M | $102.4M | $73.6M |
| Gross profit | $46.0M | $42.3M | $39.2M | $29.4M | $24.6M |
| Selling, general & administrative | $29.3M | $24.1M | $22.2M | $22.2M | $17.8M |
| Research and development | $10.4M | $8.3M | $7.5M | $7.1M | $6.8M |
| Operating expenses | $51.9M | $32.3M | $29.7M | $29.3M | $24.6M |
| Operating income | -$5.9M | $10.0M | $9.5M | $129,000 | $35,000 |
| Interest expense | $4.0M | $1.9M | $2.0M | $951,000 | $242,000 |
| Pretax income | -$8.4M | $8.3M | $9.1M | -$446,000 | -$151,000 |
| Income tax expense | -$2.4M | $1.9M | $2.0M | -$326,000 | $79,000 |
| Net income | -$5.9M | $6.3M | $7.2M | -$119,000 | -$234,000 |
| Balance Sheet | |||||
| Cash and equivalents | $9.3M | $6.9M | $10.2M | $5.6M | $8.3M |
| Current assets | $105.8M | $97.2M | $90.2M | $79.0M | $66.5M |
| Total assets | $216.9M | $220.5M | $178.3M | $168.4M | $159.5M |
| Current liabilities | $37.3M | $29.3M | $23.7M | $28.9M | $18.9M |
| Total liabilities | $86.8M | $86.3M | $52.8M | $52.0M | $41.8M |
| Stockholders' equity | $130.0M | $134.0M | $125.3M | $116.3M | $117.6M |
| Cash Flow Statement | |||||
| Cash from operations | $11.0M | $16.6M | $1.9M | -$1.3M | $4.3M |
| Depreciation and amortization | $4.0M | $3.1M | $3.0M | $3.2M | $2.9M |
| Stock-based compensation | $935,000 | $698,000 | $528,000 | $776,000 | $671,000 |
| Capital expenditure | $3.9M | $1.9M | $2.6M | $1.7M | $2.8M |
| Free cash flow | $7.1M | $14.7M | -$623,000 | -$2.9M | $1.5M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 16.7M · Free float 17.0%
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.